MCRB

1.2406.77%
SA

Stephen A. Berenson

Independent Director

Mr. Stephen A. Berenson was Executive Chairman of LARONDE, Inc. from February 2025 to March 2026. He was Director of Sail Biomedicines, Inc. He was Independent Chairman of Seres Therapeutics, Inc. from December 2019 until March 2026. He joined Seres Therapeutics, Inc. on August 06, 2019. He is Director of Seres Therapeutics, Inc. since August 06, 2019 and serves as its Independent Director. He is Managing Partner Emeritus of Flagship Pioneering, Inc from 2025. He was Managing Partner of Flagship Pioneering, Inc from July 2017 to 2025. He is Director of Inari Agriculture, Inc. from 2024. He spent years in various roles as an investment banker at J.P. Morgan, serving in the role of Vice Chairman of Investment Banking from 2005 to April 2017, where he focused on providing high-touch strategic advice and complex transaction execution to leading companies across all industries globally. He was co-founder of J.P. Morgan’s Global Strategic Advisory Council and co-founder of the firm’s Board Initiative. He served as a Chairperson of Cellarity, Inc. He was Independent Non Executive Director of Moderna, Inc. from October 10, 2017 to August 5, 2024. He was employed at Moderna, Inc. from October 10, 2017 to August 5, 2024. He was Director of CiBO Technologies, Inc. from November 2017 to 2022. He was employed at CiBO Technologies, Inc. from November 02, 2017 to 2022. He was Director of Repertoire Immune Medicines, Inc. from June 2021 to February 2024. He was employed at Repertoire Immune Medicines, Inc. until February 2024. He has B.S. in Mathematics from Massachusetts Institute of Technology from 1980 to 1982.

Positions